Focus: deCode Genetics is an Iceland-based biotech services company founded in 1996, specializing in genetic research and biomarker discovery across neurology, infectious diseases, cardiovascular, and metabolic disease areas. The company operates as a research and clinical services provider with a lean operational footprint.
Profile data last refreshed 17h ago · AI intelligence enriched 1w ago
Best suited for specialized biotech researchers or business development professionals seeking a niche role in genetic biomarker discovery, but limited career growth and financial opacity present material risk.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for deCode Genetics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from deCode Genetics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo